Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The need for and characteristics of randomized, phase III trials to evaluate symptom management in patients with cancer.

Literature DB >> 12189214

The need for and characteristics of randomized, phase III trials to evaluate symptom management in patients with cancer.

Claudette G Varricchio, Jeff A Sloan.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2002 PMID： 12189214 DOI： 10.1093/jnci/94.16.1184

Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Lifting symptom burden--how far off the ground are we?

Authors: Mellar P Davis; Jordanka Kirkova
Journal: Support Care Cancer Date: 2008-02-07 Impact factor: 3.603

2. The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591).

Authors: Pamela J Atherton; Deborah W Watkins-Bruner; Carolyn Gotay; Carol M Moinpour; Daniel V Satele; Kathryn A Winter; Paul L Schaefer; Benjamin Movsas; Jeff A Sloan
Journal: J Pain Symptom Manage Date: 2015-05-30 Impact factor: 3.612

3. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.

Authors: Chantal Quinten; John Maringwa; Carolyn C Gotay; Francesca Martinelli; Corneel Coens; Bryce B Reeve; Henning Flechtner; Eva Greimel; Madeleine King; David Osoba; Charles Cleeland; Jolie Ringash; Joseph Schmucker-Von Koch; Martin J B Taphoorn; Joachim Weis; Andrew Bottomley
Journal: J Natl Cancer Inst Date: 2011-12-07 Impact factor: 13.506

4. Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Authors: Deborah Watkins Bruner; Laura J Hanisch; Bryce B Reeve; Andy M Trotti; Deborah Schrag; Laura Sit; Tito R Mendoza; Lori Minasian; Ann O'Mara; Andrea M Denicoff; Julia H Rowland; Michael Montello; Cindy Geoghegan; Amy P Abernethy; Steven B Clauser; Kathleen Castro; Sandra A Mitchell; Laurie Burke; Ann Marie Trentacosti; Ethan M Basch
Journal: Transl Behav Med Date: 2011-03 Impact factor: 3.046

5. Toxicity and quality of life outcomes in ovarian cancer patients participating in randomized controlled trials.

Authors: Elfriede R Greimel; Vesna Bjelic-Radisic; Jacobus Pfisterer; Felix Hilpert; Fedor Daghofer; Eric Pujade-Lauraine; Andreas du Bois
Journal: Support Care Cancer Date: 2010-08-06 Impact factor: 3.603

6. Concordance between patient reports of cancer-related symptoms and medical records documentation.

Authors: Alla Sikorskii; Gwen Wyatt; Deimante Tamkus; David Victorson; Mohammad Hossein Rahbar; Suzie Ahn
Journal: J Pain Symptom Manage Date: 2012-06-13 Impact factor: 3.612

Review 7. Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.

Authors: Deborah Watkins Bruner; Charlene J Bryan; Neil Aaronson; C Craig Blackmore; Michael Brundage; David Cella; Patricia A Ganz; Carolyn Gotay; Pamela S Hinds; Alice B Kornblith; Benjamin Movsas; Jeff Sloan; Lari Wenzel; Giles Whalen
Journal: J Clin Oncol Date: 2007-11-10 Impact factor: 44.544